MARKET IS CLOSED
Loading latest tickers...

Market Indices

S&P 500
$7,722.72
+0.73%
NASDAQ 100
$30,807.93
+1.00%
DOW JONES
$51,177.00
+0.49%
NASDAQ Composite
$27,190.86
+1.19%
RUSSELL 2000
$2,815.20
+0.90%
CBOE VIX
$15.31
-6.59%

Sector Heatmap

Technology+1.01%
Financials+0.06%
Healthcare-0.01%
Consumer Cycl+1.13%
Consumer Staples+0.25%
Energy+0.40%
Industrials+0.78%
Materials+0.66%
Real Estate+0.32%
Utilities+0.38%
Comm Services+0.35%

BVS — Bioventus Inc. Class A Common Stock

Nasdaq

Bioventus Inc. Class A Common Stock

CompareBack to Screener
$13.13
-0.32(-2.38%)
O
13.52
H
13.52
L
13.02
V
362.36K
⏱️ End-of-day dataAs of Oct 2, 2026

Chart

About BVS

Bioventus Inc is a medical device company focused on developing and commercializing products to relieve pain and address musculoskeletal conditions. The company operates through two reporting segments, U.S. and International, and its product portfolio is organized into three main business areas: Pain Treatments, Surgical Solutions, and Restorative Therapies, offering products such as hyaluronic acid injections for osteoarthritis, peripheral nerve stimulation devices, bone graft substitutes, and ultrasound-based fracture healing therapies.

IndustrySURGICAL & MEDICAL INSTRUMENTS & APPARATUS
SectorNot available
IPO DateFeb 11, 2021
Employees950
Stock ExchangeNasdaq
Ticker SymbolBVS

Key Financial Statistics

Market Cap$943.29M
P/E RatioN/A
Dividend YieldNone
EPSN/A
BetaN/A
52-Week Range$6.37 - $15.89
52-Week Avg Volume475.7K
VWAP$13.18
Transactions6,775
Total Recorded Bars1,417 days